Getting Zepbound is more straightforward than getting an off-label drug, but it still has exactly one kind of starting point: a prescription from a licensed clinician. There are three practical routes to that prescription, and they differ mostly in convenience. This piece is about access; for what you’ll actually pay once you have a prescription, see Zepbound cost.
First, who qualifies
Zepbound (tirzepatide) is FDA-approved for chronic weight management in adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher (overweight) plus at least one weight-related condition — such as high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease.[1] It is separately approved for moderate-to-severe obstructive sleep apnea in adults with obesity.[1] A legitimate prescriber will check that you meet these criteria; a service that prescribes it to anyone regardless of BMI is a red flag, not a convenience.
One access route worth knowing about if you have Medicare: a temporary CMS “GLP-1 Bridge” program launched July 1, 2026 gives eligible Medicare Part D and Medicare Advantage members access to the Zepbound KwikPen for a flat $50 copay per 30-day supply, running through December 31, 2027, for beneficiaries with a BMI of 35+, or a lower BMI plus a qualifying condition.[4] It runs alongside — not instead of — the three routes below, since you still need a qualifying prescription either way.
The three routes to a prescription
In person. Your primary-care clinician or an obesity-medicine specialist can evaluate you, confirm you qualify, and send the prescription to a pharmacy. This is the route that integrates best with the rest of your care and your existing insurance.
Telehealth. A licensed telehealth platform can do the evaluation by video or questionnaire-plus-review, confirm eligibility, and prescribe. The good ones still involve a real clinician and real follow-up; the test is whether there’s a licensed prescriber accountable for your care, not just a checkout flow.
LillyDirect. Lilly’s own platform connects patients to independent telehealth prescribers and fulfills the medication — shipping single-dose vials at the self-pay prices covered in our cost guide.[2] It’s a streamlined cash route for people without coverage; a valid prescription is still required.
| Route | Best for | Prescription required? |
|---|---|---|
| In-person clinician | Integrated care + using insurance | Yes |
| Telehealth platform | Convenience with a real prescriber | Yes |
| LillyDirect | Cash self-pay, vials shipped | Yes |
| 'Research' / no-Rx sellers | Nothing — avoid | No (not legitimate) |
What a legitimate visit looks like
Whichever route you choose, a credible evaluation covers your weight history and BMI, your other medical conditions and medications, and a plan for follow-up — because Zepbound is titrated slowly from a 2.5 mg starting dose and monitored for tolerability. If a service skips the eligibility check, prescribes without any clinician review, or won’t be there for follow-up, that’s not a faster version of the same thing — it’s a worse one.
The honest bottom line
To get Zepbound: confirm you meet the BMI criteria, then choose a route to a prescription — your own clinician (best if you’re using insurance), a legitimate telehealth platform (convenient), or LillyDirect (a clean cash route with vials shipped). All three require a real prescription and a real evaluation, and that’s the feature, not the friction. Once you have it, the cost guide covers what you’ll pay, and Zepbound vs Wegovy covers whether it’s the right GLP-1 for you. Our guide to GLP-1 providers lays out the telehealth options.